Latest AI and machine learning research in dementia for healthcare professionals.
Biological heterogeneity in Alzheimer's Disease (AD) poses a critical diagnostic challenge, particularly for traditional linear methods that fail to capture non-linear neural dynamics. To address this, we propose a diagnostic framework utilizing the Large Brain Model (LaBraM), pretrained on over 2,500 hours of EEG data. By integrating these high-dimensional latent embeddings with a non-linear Rand...
Neuropsychiatric symptoms (NPS) are increasingly recognized as critical components of the disease progression in Alzheimer's disease (AD), yet their relationship with neurodegeneration remain poorly characterized. We investigated the multivariate relationships between structural MRI (sMRI)-based regional neurodegenerative biomarkers and NPS using the Alzheimer's Disease Neuroimaging Initiative (AD...
Early identification of cognitive impairment remains challenging in settings where comprehensive cognitive and clinical assessments are not available....
Spoken-language analysis via prompt-based domain-adaptive models is a promising direction for low-resource, non-invasive dementia screening, but such ...
Aging is a progressive decline in biological function that is proposed to be driven by the accumulation of epigenetic noise and the loss of epigenetic...
Background and Objectives: Word-finding difficulty is common in healthy aging and in neurologic disorders, including temporal lobe epilepsy (TLE) and ...
Background Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors are increasingly used for type 2 di...
In Alzheimer's disease (AD), misfolded proteins emerge across the entire brain in structured, yet not rigid, spatiotemporal patterns. Yet, a systemati...
Abstract EEG foundation models (EEG-FMs) are evaluated almost entirely on disease-discrimination accuracy. A clinical biomarker additionally requires ...
Background and Objectives: Subjective cognitive decline (SCD), self-reported worsening confusion or memory over the past year, is a common early marke...
Explainability methods applied to deep learning models for Alzheimer's disease neuroimaging produce attribution maps that vary substantially across me...
Alzheimer's disease (AD) progresses as a continuous biological process, whereas most existing neuroimaging-based artificial intelligence methods remai...
Low-cost, scalable screening for dementia remains an open problem. Imaging-based diagnosis is costly and hard to deploy widely. Electroencephalography...
Real-world decision-making rarely occurs with perfect information. Instead, individuals must constantly weigh potential rewards against the probabilit...
Electroencephalography (EEG) is a promising tool for automated detection of mild cognitive impairment (MCI) and dementia, but comparisons across studi...
Neurodegenexrative diseases such as Alzheimer's disease and Parkinson's disease are diagnosed most reliably only after substantial, often irreversible...
Alzheimer's disease is a leading cause of death with no cure. Therefore, early detection is critical to slow progression and preserve quality of life....
Alzheimer's disease (AD) progression is a longitudinal process with subtle pathological cues in the early stages. Yet, computational constraints have ...
Neuroimaging and genetic testing are two important clinical references for nervous system diseases, offering complementary diagnostic information. How...
Dementia affects more than 55 million people worldwide, and its progressive decline is difficult to track using infrequent in-person assessments, whic...